Vitamin D Supplementation RCT in Infants with RS Viral Infection for Preventing Recurrent Wheeze

Phase 3

• Conditions: RS viral infection; D018357

• Registration Number: JPRN-jRCTs031200376
• Lead Sponsor: Takahashi Kyohei

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-02-26
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 140

Inclusion Criteria

(1) Rapid antigen testing or PCR for the respiratory syncytial virus is positive
(2) Patients between 2 months and 36 months old.
(3) Parents or guardians have given consent to participate in this study

Exclusion Criteria

(1) If the patient weighs less than 3 kg at the time of admission
(2) When palivizumab (Synagis) is being administered or is indicated for administration
(3) Comorbidities such as chromosomal abnormalities or respiratory diseases which may affect the course of RS virus infection.
(4) Cases requiring ventilatory management at the time of admission
(5) Use of a vitamin D product (either prescription or supplement) from birth to the time of registration
(6) If the principal investigator or research co-investigator determines that participation is inappropriate

Study & Design

• Study Type: Interventional
• Study Design: Not specified